Episode 81: Dr Clyde Smith

46:45
 
Share
 

This series is archived ("Inactive feed" status)

Please note series archiving is a new, experimental, feature of Player FM with the aim of helping users understand how we fetch series and report on any issues.

When? This feed was archived on April 09, 2018 02:58 (7M ago). Last successful fetch was on March 02, 2018 21:37 (8M ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 189834948 series 124690
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
(1:14)We review the week on the markets with Kevin Stirrat Head of Investment Strategy at Forsyth Barr. (11:58)Brian Gaynor from Milford Asset Management gives his reaction to this week’s surprise announcement from NZ First leader Winston Peters to form a new government with Labour. (17:59)While business NZ chief executive Kirk Hope discusses the potential implications for business. (22:30)Andrew's feature guest this week is NZ born research scientist Dr Clyde Smith who has been based at Stanford in the US for the last decade. They discuss the growing concern regarding antibiotic-resistant super-bugs and what is being termed the “research void” that has occurred where no significant scientific discoveries have been made in this area for more than two decades. To subscribe: www.nbr.co.nz/sunday-business

93 episodes available. A new episode about every 7 days averaging 36 mins duration .